BR112017004181A2 - ?gene, vetor, célula hospedeira, partículas similares a vírus, vacina para vírus de papiloma humano, composição imunogênica, adjuvante, método para o preparo de uma vacina de papiloma humano, proteína de capsídeo principal e proteína hpv l1? - Google Patents
?gene, vetor, célula hospedeira, partículas similares a vírus, vacina para vírus de papiloma humano, composição imunogênica, adjuvante, método para o preparo de uma vacina de papiloma humano, proteína de capsídeo principal e proteína hpv l1?Info
- Publication number
- BR112017004181A2 BR112017004181A2 BR112017004181A BR112017004181A BR112017004181A2 BR 112017004181 A2 BR112017004181 A2 BR 112017004181A2 BR 112017004181 A BR112017004181 A BR 112017004181A BR 112017004181 A BR112017004181 A BR 112017004181A BR 112017004181 A2 BR112017004181 A2 BR 112017004181A2
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- human papilloma
- virus
- protein
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20071—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
a presente invenção proporciona genes que codificam vários antígenos de hpv de diversos sorotipos. o gene da presente invenção produz partículas similares a vírus com uma qualidade imunológica aprimorada e estrutura quaternária. a presente invenção também proporciona uma célula hospedeira adequada preferivelmente p.pastoris com elevado número de cópias de genes que codificam vários antígenos de hpv de diversos sorotipos. a presente invenção adicionalmente proporciona vacina contra antígenos de hpv com um aprimorado programa de imunização em que o regime de dosagem de vacina e a quantidade de dose de antígeno são reduzidos. a presente invenção também proporciona uma composição aprimorada de vacina para vírus de papiloma humano que usa levedura.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2905MU2014 | 2014-09-11 | ||
PCT/IN2015/000355 WO2016038625A2 (en) | 2014-09-11 | 2015-09-11 | Superior human papilloma virus antigens with superior immunological properties and vaccine containing it |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017004181A2 true BR112017004181A2 (pt) | 2017-12-05 |
Family
ID=54843870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017004181A BR112017004181A2 (pt) | 2014-09-11 | 2015-09-11 | ?gene, vetor, célula hospedeira, partículas similares a vírus, vacina para vírus de papiloma humano, composição imunogênica, adjuvante, método para o preparo de uma vacina de papiloma humano, proteína de capsídeo principal e proteína hpv l1? |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3191505A2 (pt) |
JP (1) | JP2017528137A (pt) |
CN (1) | CN107002085A (pt) |
AR (1) | AR101840A1 (pt) |
AU (1) | AU2015313756A1 (pt) |
BR (1) | BR112017004181A2 (pt) |
CA (1) | CA2958222A1 (pt) |
EA (1) | EA201790365A1 (pt) |
MA (1) | MA40624A (pt) |
WO (1) | WO2016038625A2 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104845985B (zh) * | 2014-02-18 | 2020-02-07 | 上海泽润生物科技有限公司 | 重组人乳头瘤病毒蛋白表达 |
BR112018007870A2 (pt) | 2015-10-19 | 2019-01-15 | Cadila Healthcare Ltd | composição imunogênica, método para a preparação de uma composição imunogênica, composição farmacêutica, vacina, método para estimular uma resposta imune em um paciente |
CN109750049B (zh) * | 2017-11-07 | 2023-08-18 | 上海泽润生物科技有限公司 | 重组人乳头瘤病毒52亚型蛋白表达 |
JP2021502822A (ja) * | 2017-11-14 | 2021-02-04 | フラウンホファー ゲセルシャフト ツール フェールデルンク ダー アンゲヴァンテン フォルシュンク エー.ファオ. | in vitro及びin vivoでの遺伝子送達のための非ヒトパピローマウイルス |
BR102020006846A2 (pt) * | 2020-04-03 | 2021-12-07 | Imunoscan Engenharia Molecular Ltda | Peptídeos sintéticos miméticos a proteína l1 do hpv, método de diagnóstico de hpv, sistema de diagnóstico de hpv, composição farmacêutica e uso dos mesmos no tratamento ou profilaxia do hpv |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000501285A (ja) * | 1995-11-15 | 2000-02-08 | メルク エンド カンパニー インコーポレーテッド | 合成hpv11ウイルス様粒子 |
DK0973546T3 (da) * | 1997-04-08 | 2004-06-28 | Merck & Co Inc | Stabiliserede formuleringer med human papillomavirus |
EP1700911B1 (en) * | 1997-09-05 | 2016-04-06 | Medimmune, Inc. | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs) |
MY140664A (en) * | 2003-09-29 | 2010-01-15 | Merck Sharp & Dohme | Optimized expression of hpv 45 l1 in yeast |
MY139500A (en) * | 2003-11-12 | 2009-10-30 | Merck Sharp & Dohme | Optimized expression of hpv 58 l1 in yeast |
WO2005123762A2 (en) * | 2004-06-18 | 2005-12-29 | Indian Immunologicals Ltd | Codon-optimized hpv16 li for salmonella vaccine strains against human papillomavirus type 16 |
CN101487009B (zh) * | 2008-01-15 | 2012-11-21 | 上海泽润生物科技有限公司 | 用毕赤酵母表达系统制备抗人乳头瘤病毒16型感染的疫苗的方法 |
WO2009076824A1 (zh) * | 2007-11-23 | 2009-06-25 | Shanghai Zerun Biotechnology Co., Ltd. | 人乳头状瘤病毒主要衣壳蛋白l1基因及其用途 |
CN102159239A (zh) * | 2008-07-31 | 2011-08-17 | 葛兰素史密斯克莱生物公司 | 针对hpv的疫苗 |
MX2011013566A (es) * | 2009-06-19 | 2012-06-28 | Eyegene Inc | Vacunas para cancer cervical. |
CN102154325B (zh) * | 2011-01-01 | 2013-08-21 | 上海生物制品研究所有限责任公司 | 针对人乳头瘤状病毒的疫苗及其制法和用途 |
CA2835967A1 (en) * | 2011-05-13 | 2012-11-22 | Folia Biotech Inc. | Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response |
ES2762230T3 (es) * | 2011-06-24 | 2020-05-22 | Merck Sharp & Dohme | Formulaciones de vacuna contra el HPV que comprenden un adyuvante de aluminio y métodos de producción de las mismas |
KR101559622B1 (ko) * | 2012-07-30 | 2015-10-13 | 중앙대학교 산학협력단 | 인유두종바이러스 바이러스 유사입자의 고효율 정제방법 |
CN103667319B (zh) * | 2012-09-10 | 2017-09-26 | 同济大学 | 抗人乳头瘤病毒的三价疫苗及其制法和用途 |
-
2015
- 2015-09-11 WO PCT/IN2015/000355 patent/WO2016038625A2/en active Application Filing
- 2015-09-11 AU AU2015313756A patent/AU2015313756A1/en not_active Abandoned
- 2015-09-11 CN CN201580049136.4A patent/CN107002085A/zh active Pending
- 2015-09-11 EP EP15808033.3A patent/EP3191505A2/en not_active Withdrawn
- 2015-09-11 CA CA2958222A patent/CA2958222A1/en not_active Abandoned
- 2015-09-11 AR ARP150102901A patent/AR101840A1/es unknown
- 2015-09-11 EA EA201790365A patent/EA201790365A1/ru unknown
- 2015-09-11 BR BR112017004181A patent/BR112017004181A2/pt not_active Application Discontinuation
- 2015-09-11 JP JP2017513424A patent/JP2017528137A/ja active Pending
- 2015-09-11 MA MA040624A patent/MA40624A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
MA40624A (fr) | 2016-03-17 |
CN107002085A (zh) | 2017-08-01 |
EP3191505A2 (en) | 2017-07-19 |
JP2017528137A (ja) | 2017-09-28 |
AR101840A1 (es) | 2017-01-18 |
WO2016038625A3 (en) | 2016-04-28 |
CA2958222A1 (en) | 2016-03-17 |
EA201790365A1 (ru) | 2017-07-31 |
AU2015313756A1 (en) | 2017-03-09 |
WO2016038625A2 (en) | 2016-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017004181A2 (pt) | ?gene, vetor, célula hospedeira, partículas similares a vírus, vacina para vírus de papiloma humano, composição imunogênica, adjuvante, método para o preparo de uma vacina de papiloma humano, proteína de capsídeo principal e proteína hpv l1? | |
CY1122872T1 (el) | Ανασυνδυασμενοι hvt φορεις οι οποιοι εκφραζουν αντιγονα παθογονων των πτηνων και χρησεις αυτων | |
PH12017500727A1 (en) | Modified virus-like particles of cmv | |
WO2015142671A3 (en) | Influenza virus vectors and uses therefor | |
MX2023006203A (es) | Vacunas novedosas contra el virus de zika. | |
MX2015008847A (es) | Composiciones inmunogenicas de virus de influenza y usos de las mismas. | |
PH12019500591A1 (en) | Canine adenovirus vectors | |
WO2016191641A3 (en) | Methods for enhancing antigen-specific immune responses using combination therapy comprising papillomavirus capsid antigens | |
MX2013010620A (es) | Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo. | |
EA201491171A1 (ru) | Вещества, содержащие улучшенные генетические конструкции il-12, вакцины, иммунотерапевтические составы и способы их применения | |
MX349657B (es) | Composiciones de vacuna de matriz de proteína que incluyen policationes. | |
NZ741875A (en) | Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof | |
BR112016026651A2 (pt) | evolução de vesículas semelhantes a vírus de alta titulação para aplicações de vacina | |
PH12014501795A1 (en) | Rota virus subunit vaccines and methods of making and use thereof | |
BR112012029633A8 (pt) | Vetores do parapoxvírus contendo antígeno do vírus da raiva. | |
BR112018000037A2 (pt) | partículas semelhantes a vírus recombinantes usando a proteína gag do vírus da imunodeficiência bovina (vlp de bgag), vacina, vetor plasmidial de transferência para produzir a vlp de bgag, método para fazer a vlp de bgag, método para preparar a vacina | |
MX2019007924A (es) | Vacunas contra la influenza. | |
BR112014026812A8 (pt) | Antígenos e combinações de antígenos | |
MX360449B (es) | Vacunas para el virus del papiloma humano y metodos para su uso. | |
BR112015013846A2 (pt) | Composição de antígeno | |
WO2013036745A3 (en) | Ipnv-isav bivalent vaccine using a virus-like particle-based platform and methods of using the same | |
BR112017012998A2 (pt) | vírus da varíola suína recombinante (rspv), molécula de ácido nucleico, célula hospedeira, método para produzir um rsvp, composição, e kit de vacinação para imunizar um porcino |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |